Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–directed Transperineal Biopsy

Mottet, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003 Bjurlin, 2020, Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer, J Urol, 203, 706, 10.1097/JU.0000000000000617 Cornud, 2018, Precision matters in MR imaging-targeted prostate biopsies: evidence from a prospective study of cognitive and elastic fusion registration transrectal biopsies, Radiology, 287, 534, 10.1148/radiol.2017162916 Ahdoot, 2020, MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis, N Engl J Med, 382, 917, 10.1056/NEJMoa1910038 Weinreb, 2016, PI-RADS Prostate Imaging — Reporting and Data System: 2015, version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052 Renard-Penna, 2015, Prostate Imaging Reporting and Data System and Likert Scoring System: multiparametric MR imaging validation study to screen patients for initial biopsy, Radiology, 275, 458, 10.1148/radiol.14140184 Hofbauer, 2018, Validation of Prostate Imaging Reporting and Data System version 2 for the detection of prostate cancer, J Urol, 200, 767, 10.1016/j.juro.2018.05.003 Manceau, 2020, Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions, Urol Oncol, 38, 10.1016/j.urolonc.2020.03.023 Mehralivand, 2017, Prospective evaluation of PI-RADS version 2 using the International Society of Urological Pathology Prostate Cancer Grade Group System, J Urol, 198, 583, 10.1016/j.juro.2017.03.131 Wajswol, 2020, A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection, BJU Int, 125, 531, 10.1111/bju.14957 Wibulpolprasert, 2020, Influence of the location and zone of tumor in prostate cancer detection and localization on 3-T multiparametric MRI based on PI-RADS version 2, AJR Am J Roentgenol, 214, 1101, 10.2214/AJR.19.21608 Gold, 2019, Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?, World J Urol, 37, 235, 10.1007/s00345-018-2337-0 Covin, 2019, Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies, World J Urol, 37, 269, 10.1007/s00345-018-2459-4 Epstein, 2017, Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 41, 10.1097/PAS.0000000000000820 Van der Kwast, 2013, Defining the threshold for significant versus insignificant prostate cancer, Nat Rev Urol, 10, 473, 10.1038/nrurol.2013.112 Gnanapragasam, 2018, The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study, BMC Med, 16, 31, 10.1186/s12916-018-1019-5 Drost, 2020, Prostate Magnetic Resonance Imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis, Eur Urol, 77, 78, 10.1016/j.eururo.2019.06.023 Rouviere, 2019, EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guidelines Panel. Multiparametric magnetic resonance imaging before prostate biopsy: a chain is only as strong as its weakest link, Eur Urol, 75, 889, 10.1016/j.eururo.2019.03.023 Schouten, 2017, Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naive men?, Eur Urol, 71, 896, 10.1016/j.eururo.2016.12.006 Borghesi, 2017, Complications after systematic, random, and image-guided prostate biopsy, Eur Urol, 71, 353, 10.1016/j.eururo.2016.08.004 Loeb, 2012, Infectious complications and hospital admissions after prostate biopsy in a European randomized trial, Eur Urol, 61, 1110, 10.1016/j.eururo.2011.12.058 Ploussard, 2020, Assessment of the minimal targeted biopsy core number per MRI lesion for improving prostate cancer grading prediction, J Clin Med, 9, 225, 10.3390/jcm9010225 Bhandari, 2019, Molecular landmarks of tumor hypoxia across cancer types, Nat Genet, 51, 308, 10.1038/s41588-018-0318-2 Houlahan, 2019, Molecular hallmarks of multiparametric magnetic resonance imaging visibility in prostate cancer, Eur Urol, 76, 18, 10.1016/j.eururo.2018.12.036 Gordetsky, 2019, Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection, Hum Pathol, 83, 159, 10.1016/j.humpath.2018.08.021 Krieger, 2008, Epidemiology of prostatitis, Int J Antimicrob Agents, 31 Kitzing, 2016, Benign conditions that mimic prostate carcinoma: MR imaging features with histopathologic correlation, Radiographics, 36, 162, 10.1148/rg.2016150030 Lee, 2019, Multiparametric MRI appearances of primary granulomatous prostatitis, Br J Radiol, 92 Sureka, 2019, Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study, Br J Radiol, 92, 10.1259/bjr.20190181 Wang, 2017, Searching for prostate cancer by fully automated magnetic resonance imaging classification: deep learning versus non-deep learning, Sci Rep, 7, 15415, 10.1038/s41598-017-15720-y Roumiguie, 2020, Independent evaluation of the respective predictive values for high-grade prostate cancer of clinical information and RNA biomarkers after upfront MRI and image-guided biopsies, Cancers (Basel), 12, 285, 10.3390/cancers12020285 Westphalen, 2020, Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel, Radiology, 296, 76, 10.1148/radiol.2020190646 Panda, 2019, MR fingerprinting and ADC mapping for characterization of lesions in the transition zone of the prostate gland, Radiology, 292, 685, 10.1148/radiol.2019181705 McKenney, 2011, The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study, J Urol, 186, 465, 10.1016/j.juro.2011.03.115 Westhoff, 2017, Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms, World J Urol, 35, 1015, 10.1007/s00345-016-1967-3 Podder, 2008, Methods for prostate stabilization during transperineal LDR brachytherapy, Phys Med Biol, 53, 1563, 10.1088/0031-9155/53/6/004 Elfatairy, 2020, In-bore MRI-guided prostate biopsies in patients with prior positive transrectal US-guided biopsy results: pathologic outcomes and predictors of missed cancers, Radiol Imaging Cancer, 2, 10.1148/rycan.2020190078 Gandaglia, 2020, Eur Urol, 77, 733, 10.1016/j.eururo.2019.09.005 Gandaglia, 2019, A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies, Eur Urol, 75, 506, 10.1016/j.eururo.2018.10.012